4th Annual Pathogen Clean Asia Forum, Shanghai, China

The risk of adventitious viral and pathogen contamination is highly relevant to most of all biotechnology products derived from cell lines of human or animal origin as well as plasma/plasma-derived medicinal products. Such contamination event could possibly elicit serious consequences including risk to patients, shortage of product supply and the substantialities of the business. Therefore, it is expected the viral safety of medicinal products shall be reasonably assured through the application of a rigorius testing and control program and robust assessment of virus removal and inactivation achieved through the manufacturing and purification process. And based upon the first three years’ program, through collaborating with International Serum Industry Association and leading KOLs, the PCA2017 forum aims to build up and facilitate the progressive regulatory, scientific and technical communication to advocate the Safety and Quality profiles of bio-therapeutics in the region.